The Government Accountability Office (GAO) has issued a number of health policy reports recently, including “Medicare Advantage: Increased Spending Relative to Medicare Fee-for-Service May Not Always Reduce Beneficiary Out-of-Pocket Costs”; “Medicaid Demonstration Waivers: Recent HHS Approvals Continue to Raise Cost and Oversight Concerns”; and “Reprocessed Single-Use Medical Devices: FDA Oversight Has Increased, and Available Information Does Not Indicate That Use Presents an Elevated Health Risk “.